StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Total Financial Debts by Quarter

Total Financial Debts ($M)

QuarterlyAnnual

Novartis Total Financial Debts: $46,349M in Q3 2026, up 53.9% from a year earlier.

Latest, Q3 2026
46,349
Period ended Sep 30, 2026
Change on a year earlier
+53.9%
30,118 in Q3 2025
History
19 quarters
Since Q4 2021
Sources
19
Documents cited below

Where the Q3 2026 figure comes from

“|| Total financial debts | – 46 349 | – 33 537 | – 30 118”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Financial Debts ($M)Year on yearSource
Q3 2026Sep 30, 202646,349+53.9%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202647,077+52.9%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202645,064+52.9%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202533,537+13.3%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202530,118-0.7%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202530,784+13.2%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202529,467+15.4%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202429,598+20.3%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202430,316+28.9%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202427,195+2.4%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202425,530-6.7%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202324,611-6.0%Novartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 202323,526-12.2%Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202326,548-9.3%Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 202327,364–Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 202226,175-10.4%Novartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis Total Financial Debts ($M), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/nd-total-fin-debts

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.